First documented cases of systemic lupus erythematosus in niger

##plugins.themes.academic_pro.article.sidebar##

Published Dec 2, 2015
Download
pdf
Vol. 93 No. 7 (2015): Issue Jul 2015

##plugins.themes.academic_pro.article.main##

Brah Souleymane
Daou Mamane
Malam Abdou
Mahamane Sani Mahaman
Adamou Hamadou
Alhousseini Maïga Daouda
Parola Philippe
Adehossi Eric

Abstract

SUMMARY
Objective: We describe in this first series of lupus documented in Niger, the epidemiological, diagnostic, therapeutic and prognostic aspects.
Method: This is a prospective study in internal medicine at the National Hospital of Niamey during 10 years. ACR criteria were used as diagnostic criteria.
Results: We identified only 9 cases with a frequency of 0.05 % (7 women, 2 men) with a mean age of 36.7 years [range, (26, 48)]. Frequent manifestations were prolonged fever (8 cases), malar rash (6 cases), arthritis (6 cases), alopecia (5 cases), discoid lupus (3 cases), haematological disorders (7 cases), serositis (4 cases) and renal failure (4 cases). All patients had at least 4 ACR criteria with an average of 6.11 criteria. ANA were positive in 8 patients with an average of 1/568, 68 [extremes (1/1280-1/160)]. The most commonly molecules used were Prednisone, Azathioprine and Hydroxychloroquine. The Mycofénolate Mofétil, Cyclophosphamide and Rituximab were used in a single patient. The outcome was favorable in 8 patients and we deplore the death of one patient.
Conclusion: Under diagnosis would be the basis of the low prevalence of lupus in Niger. Diagnostic means are necessary for epidemiological studies in order to have more representative data.

Keywords:

Lupus, Diagnostic, epidemiology, Niamey, Niger

##plugins.themes.academic_pro.article.details##

References

  1. Basset A, Hocquet P, Sow A M, Richir C L. A propos d'un cas de lupus érythémateux disséminé. Bull. Soc. Bull. Soc. Med. Afr. Noire Lgue Frse, 1960;5:172-5.
  2. Iba Ba J, Nzenze JR, Biteghe B, Missounga L, Bignoumba Ibouili R, Moussavou Kombila JB et coll. Profil clinique, biologique et évolutif du lupus systémique en milieu hospitalier à Libreville. Médecine d'Afrique Noire 2011;5812:551-559
  3. Fall S, Pouye A, Ndiaye FS, Ndongo S, Leye Y, Dioum A et coll. Présentation initiale du lupus érythémateux systémique au Sénégal. Médecine d'Afrique Noire 2011; 5803:156-160.
  4. Daboiko JC, Gueret M, Eti E, Ouali B, Ouattara B, Gbane M et coll. Profil clinique et évolutif du lupus érythémateux systémique à Abidjan : Ã propos de 49 cas colligés au CHU de Cocody. Médecine d'Afrique Noire 2004;5103:143-146.
  5. Ka M.M, Diallo S, Kane A, Wade B, Mbengue M, Diouf B et coll. Systemic lupus erythematosus and lupus syndrome in Senegal. A retrospective study of 30 patients seen over 10 years. Rev Rhum Eng 1998;65:471- 6.
  6. Taylor H G, Stein M C. Systemic lupus erythematosus in Zimbabwe. Ann Rheum Dis 1986; 45: 645-8.
  7. Olivier Meyer. Lupus systémique chez les non-Caucasiens. Rev Rhum 2002;69:801-8.
  8. Hopkinson ND, Doherty M, Powell RJ. Clinical features and race specific incidence prevalence rates of systemic lupus erythematosus in a geographically complete cohort of patients. Ann Rheum Dis 1994;53:675-80.
  9. Bach J-F. Infections and autoimmunity. J Autoimmun 2005; 25:74-80.
  10. Yazdanbakhsh M, Kremsner PG, van Ree R. Allergy, parasites and the hygiene hypothesis. Science 2002;296:490-4.
  11. Vercelli D. Mechanisms of the hygiene hypothesis - molecular or otherwise. Curr Opin Immunol 2006;18:733-7.
  12. Liu AH, Leung DYM. Renaissance of the hygiene hypothesis. J Allergy Clin Immunol 2006;117:1063-6.
  13. Cooper GS, Dooley MA, Treadwell EL, Clair EWS, Gilkeson GS. Risk factors for development of systemic lupus erythematosus: Allergies, infections, and family history. J Clin Epidemiol. 2002;55:982-9.
  14. Blank M, Barzilai O, Shoenfeld Y. Molecular mimicry and autoimmunity.Clin Rev Allergy Immunol 2007;32:111 - 8.
  15. Sundar K, Jacques S, Gottlieb P, Villars R, Benito M-E, Taylor DK et coll. Expression of the Epstein-Barr virus nuclear antigen -1 (EBNA-1) in the mouse can elicit the production of anti-dsDNA and anti-Sm antibodies. J Autoimmun 2004;23:127- 40.
  16. Severin MC, Levy L, Shoenfeld Y. Systemic lupus erythematosus and parvovirus B-19: causal coicidence or causative culprit? Clin Rev Allergy Immunol 2003;25:41-8.
  17. Sonja P, Snezna S-S, Matija T, Yehuda S. The curiously suspicious: Infectious disease may ameliorate an ongoing autoimmune destruction in systemic lupus erythematosus patients. Journal of Autoimmunity 2008;30: 37-41.
  18. Nossent J. Course and prognostic value of systemic lupus erythematosus disease activity index in black caribbean patients. Semin Arthritis Rheum 1993;23:16-21.
  19. Hochberg MC, Boyd RE, Ahearn JM, Arnett FC, Bias WB, Provost TT et coll. Systemic lupus erythematosus : a review of clinico-laboratory features and immunogenetic markers in 150 patients with emphasis on demographic subsets. Medicine 1985;64:285-95.
  20. Mahfoudh A, Khaled A, Chtourou O, Kharfi M, Zeglaoui F, Fazaa B et coll. Chronic lupus erythematosus: 104 Tunisian cases. Tunis Med. 2010;88:742-5.
  21. Arfaj AS Al, Khalil N. Clinical and immunological manifestations in 624 SLE patients in Saudi Arabia. Lupus 2009;18: 465-473
  22. Eti E, Hayam G, De Bandt M, Tubach F. SLE in black patients from Africa and the French West Indies. Spectrum and race differences. Clin Exp Rheumatol 1998;16:762-3.
  23. Tikly M, Burgin S, Mohanlal P, Belligan A, Goerge J. Autoantibodies in black South African with systemic lupus erythematosus : spectrum and clinical associations. Clin Rheumatol 1996;15:261-5.
  24. Amoura Z, Huong Du LT, Cacoub P, Frances C, Piette JC. Systemic lupus erythematosus in patients native to West and Central Africa: comment on the article by Bae et al. Arthritis Rheum 1999;42:1560-1.
  25. Morrisson RCA, Gear AJ, Kark A, Meyers A, Goldberg B. Differences in systemic lupus erythematosus among 4 racial groups in South Africa. Arthritis Rheum 1990;33:104.